Earnings Feed
Start Free
Home/Insiders/Hahn Mark W
HM
SEC Insider//CIK 0001408502

Hahn Mark W

CIK 00014085026 companiesCHAPEL HILL, NC
SEC Profile

Transactions

50

Companies

6

Filings

7

CIK

0001408502

Recent Transactions

50 trades
  • Award
    SOLENO THERAPEUTICS INC$SLNO

    Common Stock

    2025-10-13+10,046→ 10,046 total
  • Disposition to Issuer
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-10-07−11,264,968→ 0 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Unit

    2025-10-07−1,649,952→ 0 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-10-07+3,285,280→ 3,285,280 total
  • Disposition to Issuer
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-10-07−3,285,280→ 0 total
  • Award
    Verona Pharma plc$VRNA

    Restricted Share Unit

    2025-10-07+1,649,952→ 1,649,952 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Unit

    2025-10-07−389,792→ 0 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Unit

    2025-10-07−445,536→ 0 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Unit

    2025-10-07−800,000→ 0 total
  • Gift
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-08-29−1,200,000→ 11,264,968 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Stock Units

    2025-08-01−55,696→ 389,792 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-08-01+255,696→ 12,673,880 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Stock Units

    2025-08-01−200,000→ 800,000 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-08-01$13.14/sh−208,912→ 12,464,968 total
  • Tax Payment
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-07-08$11.44/sh−90,320→ 12,418,184 total
  • Award
    Verona Pharma plc$VRNA

    Restricted Share Units

    2025-07-07+675,048→ 675,048 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Units

    2025-07-07−229,512→ 445,536 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-07-07+229,512→ 12,508,504 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-06-11$11.40/sh−400,000→ 12,278,992 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-05-29$9.33/sh−204,864→ 12,678,992 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-05-28$9.30/sh−162,704→ 12,883,856 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-05-27$9.53/sh−32,432→ 13,046,560 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-05-02$9.09/sh−400,000→ 13,078,992 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-05-01+200,000→ 13,557,728 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Units

    2025-05-01−200,000→ 1,000,000 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-05-01$8.95/sh−108,272→ 13,357,728 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-05-01$8.95/sh−78,736→ 13,478,992 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-04-29+229,512→ 13,556,360 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-04-29$8.98/sh−90,360→ 13,466,000 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Units

    2025-04-29−229,512→ 445,488 total
  • Award
    Verona Pharma plc$VRNA

    Restricted Share Units

    2025-04-29+675,000→ 675,000 total
  • Tax Payment
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-02-03$7.16/sh−166,888→ 13,326,848 total
  • Award
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-02-01+200,000→ 13,493,736 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-12-06$5.01/sh−183,728→ 13,293,736 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-12-05$5.01/sh−640,048→ 13,477,464 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-12-04$5.00/sh−58,184→ 14,117,512 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-12-02$5.00/sh−1,600→ 14,175,696 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-11-29$5.01/sh−98,704→ 14,177,296 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-11-27$5.00/sh−12,936→ 14,276,000 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-11-26$5.00/sh−800→ 14,288,936 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-11-25$5.00/sh−1,600→ 14,289,736 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-11-11$5.00/sh−2,400→ 14,291,336 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-11-04$4.39/sh−80,784→ 14,293,736 total
  • Tax Payment
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-11-01$4.24/sh−245,952→ 14,423,408 total
  • Award
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-11-01+200,000→ 14,669,360 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-11-01$4.38/sh−48,888→ 14,374,520 total
  • Award
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-10-30+800,000→ 14,469,360 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-10-25$4.38/sh−3,200→ 13,669,360 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-10-24$4.38/sh−141,360→ 13,672,560 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-10-22$4.38/sh−159,344→ 13,813,920 total

Companies

6

Recent Filings

7

Address

6340 QUADRANGLE DRIVE SUITE 100

CHAPEL HILL, NC, 27517

View on SEC.gov